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Alterations of cathepsins B, H and L in proximal tubules from
polycystic kidneys of the Han:SPRD rat
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Alterations of cathepsins B, H and L in proximal tubules from
polycystic kidneys of the Han:SPRD rat. Abnormalities of tubular matrix
metalloproteinases have been shown recently to occur early in the course
of polycystic kidney disease (PKD). The present study was conducted to
determine whether lysosomal cysteine proteinases were altered in proxi-
mal tubules from 2-month-old, heterozygous Han:SPRD rats. The activi-
tics of cathepsins B (—45%), H (—39%) and L (—37%) were significantly
lower in proximal tubules from PKD rats as compared to healthy offspring.
Enzyme proteins were also decreased (cath. B, 2.4 0.7-fold; cath. H, 1.9
0.6-fold; N = 4, P < 0.05), while mRNA levels for cathepsins B, H and
L were not different. Tubular cystatin C, a major inhibitor of cathepsins,
was normal with regard to protein and mRNA levels in PKD animals. The
decrease in cathepsins in PKD was specific for tubules, as enzyme activities
in glomeruli and liver tissue were unchanged and limited to the lysosomal
compartment, since marker enzymes for cytoplasm, endoplasmatic retic-
ulum and mitochondria were all normal. Intralysosomally, soluble en-
zymes like cathepsins and 13-NAG were decreased, while membrane-
bound acid phosphatase was unchanged. The presence of cathepsins could
be demonstrated in cyst fluid from homozygous PKD rats and urinary
excretion of cathepsins was enhanced in heterozygous animals. Taken
together, these findings indicate that the reduction in tubular cathepsins B,
H and L was neither due to decreased gene expression nor to up-
regulation of specific inhibitors, but was likely due to enhanced apical
secretion of these enzymes.
A number of studies on human and experimental forms of
polycystic kidney disease (PKD) suggest that an abnormal matrix
plays a key role in cystogenesis [1—3]. This in turn could lead to
abnormal cell/basement membrane interactions [4, 5] that may be
central to the pathogenesis of PKD. This assumption has been
considerably strengthened recently by reports [6, 7] showing that
the PKD1 gene encodes a high molecular weight protein of circa
500,000 kDa with multiple cell recognition domains. This novel
protein which has been designated "polycystin," thus may be
involved in cell-cell/matrix interactions.
In general, the turnover of extracellular matrix components
depends on the balance between their synthesis and degradation.
Thus, excessive matrix deposition may occur either when synthesis
is enhanced and/or when the activity of proteinases is down-
regulated. Recently, we [8] and others [9] have reported on
alterations of matrix metalloproteinases (MMPs) and their inhib-
itors in tubular epithelium from polycystic kidneys.
Apart from metalloproteinases the mammalian kidney contains
high activities of cysteine proteinases, such as cathepsins B, H and
L [10, 11], both within the glomerulus and proximal tubule.
Intracellularly these enzymes are located within lysosomes. They
have a relatively broad substrate specificity and an optimum at
acidic pH [12]. Their ability to degrade intact basement mem-
branes as well as isolated matrix components has been widely
documented [10, 13—17]. Besides direct degradation of extracel-
lular matrix, cathepsin B has been found to indirectly regulate
matrix turnover by proteolytically activating prourokinase as well
as latent forms of metalloproteinases [18, 19].
Abnormalities in lysosomal proteinases in human ADPKD
epithelia have already been addressed in preliminary form by
Wilson and Hartz [20, 21]. However, until now there has been no
direct evidence for alterations in tubular cathepsins coming from
any animal model of PKD. Thus, the objective of the present study
was to investigate whether cathepsins B, H and L and their
inhibitors were altered in proximal tubules from heterozygous
PKD rats (Han:SPRD) in an early stage of cystogenesis.
Methods
Animals
Homozygously (cy/cy) and heterozygously (cy/+) affected male
Han:SPRD rats as well as healthy littermates (+/+) were used in
this study. This model of ADPKD is derived from a spontaneous
mutation in the Sprague-Dawley strain and the disease is trans-
mitted in an autosomal dominant pattern. Homozygous animals
develop excessive cysts with gross renal enlargement and die early
(after 4 weeks) from renal failure. By contrast, heterozygously
afflicted rats suffer from slow, progressive renal cystic disease and
death usually occurs after 12 to 21 months [22—24].
Heterozygously affected Han:SPRD rats (cy/+) were investi-
gated at the age of two months. Age-matched, unaffected litter-
mates (+/+) were used as control animals. The presence of
enlarged kidneys was checked by abdominal palpation and further
controlled by histopathology to identify affected animals. Cyst
fluid was obtained from homozygous three-week-old Han:SPRD
rats, because only homozygous animals develop cysts large enough
to harvest quantitative amounts of cyst fluid [24]. All animal
experiments were conducted in accord with the NIH Guide for the
Care and Use of Laboratory Animals.
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Isolation and characterization of glomeruli and proximal tubules
Animals were anesthetized with hexobarbital (150 mg/kg), the
kidneys removed and glomeruli and tubules isolated according to
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the method of Spiro [25]. In brief, renal Cortex from one kidney of
each animal was minced and resuspended in ice-cold saline. A
sample of the total homogenate was reserved and the rest of the
homogenate was passed through a stainless steel sieve (250 jsm
pore size, Linker, Kassel, Germany). The sieved material was
suspended in ice-cold saline and poured over a 50 jsm nylon sieve
(Schweizerische Seidengazefabrik, Zurich, Switzerland), thereby
allowing cell debris and small fragments to pass through, while
retaining glomeruli and tubules. Separation of tubules from
glomeruli was achieved by passage on a 150 sm nylon sieve. The
tubuli which were retained by this sieve were resuspended on 50%
Percoll and centrifuged at 12.200 g for 30 minutes at 4°C
according to Vinay et al [26]. This preparation contained proximal
tubules obtained from a single kidney after sieving and Percoll
gradient separation.
The fraction containing proximal tubules was resuspended in
0.9% saline, washed three times and then examined by light
microscopy. A sample from each preparation was also processed
for histological evaluation after formalin fixation and periodic
acid Schiff (PAS) staining. This allows for clear differentiation
between proximal (granular yellow cytoplasm and pink brush
border membrane) and distal tubular epithelia (clear cytoplasma,
no brush border membrane) [26]. The purity of the proximal
tubular preparation was 95%. Isolated proximal tubules were
either used for RNA isolation or were disrupted by sonication (5
bursts, 2 seconds each) at 4°C for the measurements of enzyme
activities.
Glomeruli were collected after passage through the 150 sm
nylon sieve. Purity, controlled by light microscopy, was 90 to 95%.
Glomeruli from each kidney preparation were counted thrice in a
Fuchs-Rosenthal chamber. Isolated glomeruli were disrupted by
sonication (3 bursts, 2 seconds each) at 4°C prior to the determi-
nation of cathepsin activities.
Preparation of liver homogenates
Portions of livers (1 g each) were homogenized in cooled
isotonic saline using 10 strokes of a Potter homogenizer. The
homogenates were sonicated (8 bursts, 2 seconds each) and then
centrifuged at 10,000 g for 10 minutes. The supernatants were
used for measuring cathepsin activities.
Cyst fluid samples
Cyst fluids from homozygous polycystic kidneys were obtained
by puncture and were free of leukocytes. Proteolytic enzyme
activities were measured in supernatants after centrifugation at
5,000 rpm for 10 minutes.
Urine samples
Urine was collected for 24 hours in metabolic cages, examined
in order to exclude the presence of leukocytes and centrifuged for
10 minutes at 5,000 rpm. Prior to protein and activity measure-
ments of cathepsins the supernatants were dialyzed for 24 hours at
4°C against four changes of a solution composed of 30 mM
potassium citrate, pH 6.0/100 mi NaC1/0.1% Triton X-100, using
dialysis sacks (Sigma, St. Louis, MO, USA) retaining proteins
greater than 12 kDa. After dialysis, urine samples were concen-
trated 25-fold by microconcentrators (Microcon 10; Amicon,
Beverly, MA, USA).
Cathepsin B, H and L activities
The activities of cathepsin B, H, and L were measured as
previously described by Barrett and Kirschke [27] and Baricos et
al [16] using fluorogenic peptidyl substrates (peptidyl-7-amido-4-
methylcoumarins, AMC; Bachem, Heidelberg, Germany): Z-Arg-
Arg-AMC for cathepsin B, H-Arg-AMC for cathepsin H and
Z-Phe-Arg-AMC as the common substrate for cathepsin B and L
in combination with 0.6 fLM of the cathepsin L inhibitor Z-Phe-
Phe-CHN2 (Enzyme Systems Products, Dublin, CA, USA). Ca-
thepsin L activity was calculated as the difference in Z-Phe-Arg-
AMC hydrolysis in the presence and absence of the cathepsin L
inhibitor. In the case of cathepsin H, 0.1 mM puromycin hydro-
chloride was used to inhibit arylamidases. Experiments addressing
the specificity of these substrates, showed 100% inhibition of
hydrolysis of each of the peptidyl 7-amino-4-methylcoumarin
substrates by a 15 minute pre-incubation with 10 .LM E-64
(cysteine proteinase inhibitor). The fluorescence of free AMC was
determined by excitation at 360 nm and emission at 460 nm using
a Luminescence Spectrometer (LS 50; Perkin Elmer, Langen,
Germany). One unit of activity was defined as the production of I
nm of AMC/min.
Western blot analysis
Prior to Western blot analysis of cathepsins B and H, homoge-
nates of proximal tubules containing equal amounts of protein or
samples of cyst fluid were semipurified as described previously
[15, 28]. Briefly, homogenates of proximal tubules were exten-
sively extracted with 0.2% (vol/vol) Triton X-100. The extracts as
well as cyst fluids were autolysed at 40°C for one hour and the
insoluble material was removed by centrifugation. Material pre-
cipitated by 30 to 70% ammonium sulphate was collected and
dialyzed against 10 m sodium acetate (pH 4.3) and subsequently
concentrated 10-fold (Microcon 10, Amicon). To determine the
rate of recovery, the activities of cathepsin B and H were
measured before and after semipurification.
Prior to Western blot analysis of cystatin A and C, homogenates
of proximal tubules containing equal amounts of protein were
treated with alkali (pH 11.0) to inactivate cellular cysteine pepti-
dases, mixed with equal volume of 0.1 M Tris-HCI buffer (pH 7.4)
containing 1.0 M NaCI and 5% inhibitor cocktail concentrate (0.1
M benzamidinum chloride, 0.2 M EDTA, 2% (wt/vol) sodium
azide) and applied to a papain affinity filtration cartridge (Sigma).
After washing with 50 mivi Tris-HC1 buffer (pH 7.4) containing 0.5
mM NaCl the bound material was eluted with 0.2 M trisodium
phosphate, pH 12.7/0.5 M NaCl and immediately neutralized with
2 M Tris-HC1, pH 7.4 [29].
SDS polyacrylamide gel electrophoresis was carried out follow-
ing the method of Laemmli [30] using 10% (wt/vol) gels for
cathepsins B and H and 15% (wt/vol) gels for cystatins A and C.
Proteins were transferred electrophoretically at 100 V for one
hour to nitrocellulose membranes using the Bio-Rad Mini Trans-
Blot Apparatus as recommended by the manufacturer. The
membranes were blocked by incubation with 1% (wt/vol) BSA in
PBS containing 0.1% (vol/vol) Tween 20 (PBST) for two hours.
After washing in PBST for 25 minutes, the nitrocellulose was
incubated over night at 4°C in PBS containing 0.05% Tween 20
and 1% BSA (PBSTB) with the following primary antibodies:
(1) Rabbit polyclonal antibody to recombinant rat cathepsin B
(provided by Dr. J.S. Mort, Montreal, Canada) in a dilution of
1:400.
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(2) Rabbit polyclonal antibody to human cathepsin H (RD
Laboratories, Diessen, Germany) in a dilution of 1:200.
(3) Rabbit polyclonal antibody to rat cystatin A (provided by Dr.
K. Fukuyama, San Francisco, CA, USA) in a dilution of 1:50
to 1:300.
(4) Rabbit polyclonal antibody to human cystatin C (RD Labo-
ratories, Diessen, Germany) in a dilution of 1:200.
(5) Rabbit polyclonal antibody to human cathepsin L (RD Lab-
oratories, Diessen, Germany).
Thereafter, the nitrocellulose strips were washed for one hour
in PBST and incubated in PBSTB containing the second antibody
in a dilution of 1:2000 (anti-rabbit IgG, peroxidase-linked, spe-
cies-specific whole antibody) from Amersham (Amersham, UK)
for one hour. The strips were then extensively washed in PBST
and incubated in ECL Western blotting detection reagent (Am-
ersham) and exposed to Kodak X-OMAT AR film.
Northern blot analysis
Northern blots were performed on total RNA extracted from
proximal tubules isolated from single animals with the acid
guanidinium thiocyanate phenol chloroform extraction method
[31]. Total RNA was quantitated by UV spectrophotometry at 260
nm and 280 nm. RNA samples (20 to 30 g per lane) were
denatured and electrophoresed through 1.2% agarose formalde-
hyde gels and then transferred by pressure blotter (Posi Blot,
Stratagene, La Jolla, CA, USA) onto nylon filters (GeneScreen,
DuPont-NEN, Boston, MA, USA). The RNA was fixed to the
filters by ultraviolet irradiation for two minutes at 254 nm (UV
Stratalinker, Stratagene).
All probes were radiolabeled with [32PJdCTP (3.000 Ci/mmol)
using the DECAprime DNA labeling kit (Ambion, Austin, TX,
USA). Membranes were prehybridized at least for two hours at
42°C in 5 X SSPE/50% deionized formamide/5X Denhard's/0.5%
SDS/50 gig/mI herring sperm DNA. Hybridization was carried out
overnight at 42°C. The filters were washed twice for 15 minutes in
2x SSPE at room temperature and then agitated in 2X SSPE/2%
SDS at 65°C for 30 minutes and exposed to Kodak X-OMAT AR
film at —80°C for one to two days. After autoradiography, the
filters were stripped and hybridized according to the same proce-
dure with a human GAPDH cDNA probe (1.2 kb Pst I restriction
fragment of pBR 322). A 0.24 to 9.5 kb RNA ladder (Gibco BRL,
Gaithersburg, MD, USA) was used as reference for RNA size.
The autoradiographs were digitized using an EPSON GT 6000
scanner (Epson, Tokyo, Japan). For all RNA samples the density
of each individual RNA band was normalized for that of a
GAPDH mRNA band to correct for the difference in RNA
loading and/or transfer. Quantitative data were presented only on
signals in the linear range of the film and the densitometer.
The plasmid containing cDNA for rat cathepsin B was provided
by Dr. S.J. Chan (Howard Hughes Medical Institute, Chicago, IL,
USA) and cDNA for murine cathepsin L was a gift from Dr. G.G.
Sahagian (Tufts University, Boston, MA, USA). The plasmid
containing cDNA for human cathepsin H was provided by Dr. J.
Dodt (University of Darmstadt, Germany) and for murine cystatin
A by Dr. K.A. Siminovitch (University of Toronto, Canada).
cDNA for murine cystatin C was obtained from ATCC (Rockville,
MD, USA).
Restriction fragments isolated from these plasmids were as
follows: EcoRl 2.0 kb fragment for cathepsin B; Pst I-BamHI 1.4
Table 1. Body, single kidney weights and renal function in
heterozygous PKD and control rats
Heterozygous
Han:SPRD animals PKD Controls
Body weight g 329 7 337 8
Kidney weight g 2.3 0.17 1.1 0.06
Serum creatinine mgldl 0.56 0.03 0.52 0.02
Creatinine clearance 481 22 496 21
pllmin/100 g
Data are given as means SEM from 9 animals in each group.
aP < 0.05 for heterozygous PKD vs. healthy offspring (2-months-old)
kb fragment for cathepsin L; EcoRI-PstI 1.1 kb fragment for
cathepsin H; XhoI 0.4 kb fragment for cystatin A; EcoRl 0.67 kb
fragment for cystatin C.
Analytical methods
Each preparartion of isolated proximal tubules and samples of
total cortical homogenates from one kidney were assayed for
fructose-1,6-diphosphatase activity according to the method of
Pontremoli et al [32]. Acid phosphatase [33], N-acetyl-glu-
cosaminidase [34], glucose-6-phosphatase [35], cytochrome C
oxidase [36] and lactate dehydrogenase [37] were assayed in the
isolated proximal tubules by established methods. Results were
expressed as U (nM of substrate converted per mm) per tubular
preparation (proximal tubules isolated from one kidney).
Tissue protein content was determined according to the method
of Smith, Krohn and Hermanson [38]. Analysis of serum and
urine samples for creatinine was performed using a Technicon
autoanalyzer (Bayer Diagnostics, Munich, Germany).
Statistics
Results were expressed as means SEM. Statistical analysis was
performed using the unpaired Student's t-test. Significance was
accepted at the 5% level.
Results
Kidney weight and fzrnction in heterozygous PKD rats
The body weight was comparable in two-month-old polycystic
(329 7 g) and control animals (337 8 g). Kidney weight was
considerably higher in PKD rats (2.3 0.2 g) than in control
animals (1.2 0.1 g) and the enlarged kidneys could be readily
detected by abdominal palpation. Polycystic animals displayed
normal glomerular filtration rates, as measured by creatinine
clearance (Table 1).
Characterization of isolated proximal tubules
Light microscopy of PAS-stained preparations revealed that
proximal tubules were isolated to a purity of 95% and no
glomeruli were detectable. To demonstrate that the isolation
procedure resulted in comparable preparations from both PKD
and control animals, the activity of fructose-1,6-diphosphatase, a
specific marker for proximal tubular epithelial cells [26], was
measured both in the kidney cortex homogenate and in the final
proximal tubule preparation. Enzyme activity in the cortical
homogenate was comparable in PKD and control rats (PKD 283,5
21.4 vs. controls 276.3 24.2 U/kidney cortex; N = 9). In
parallel, isolated tubules from the initial homogenate also dis-
played more or less identical fructose-1,6-diphosphate activities
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Table 2. Cysteine proteinase activities in proximal tubules from
heterozygous PKD and control rats
Cathepsin B Cathepsin H Cathepsin L
U/tubular preparation
PKD 4.45 0.23a 2.98 0.2P' 8.19 0.70k'
Controls 8.04 0.49 4.88 0.19 12.92 0.71
Data are given as means SEM from 9 animals in each group. Tubular
preparations represent proximal tubules from one kidney.
P < 0.05 for PKD animals vs. healthy offspring (2-months-old)
(PKD 218.3 23.2 vs. controls 216.1 20.9 U/tubular prep.; N
9). This represented a 77.0% and 78.2% recovery, respectively and
indicated that the isolation resulted in comparable tubular prep-
arations both from normal and diseased kidneys. Furthermore,
the amount of protein in both preparations was comparable (PKD
5.9 0.7 vs. controls 6.3 0.5 mg per tubular preparation; N =
9).
Cathepsins B, H and L in proximal tubules from PKD and
control rats
The activities of cathepsin B (—45%), cathepsin H (—39%) and
cathepsin L (—37%) were significantly reduced in proximal tu-
bules from PKD as compared to control animals (Table 2). This
could be due either to lower enzyme proteins or due to enhanced
levels of inhibitor proteins. Thus, Western blot analysis was
performed using polyclonal antibodies to recombinant rat cathep-
sin B or human cathepsin H. Prior to electrophoresis, homoge-
nates of proximal tubules containing equal amounts of protein
were semipurified. The recovery of cathesin B and H activities,
measured before and after purification, was comparable both in
PKD and the control groups (cathepsin B, PKD, 78.7 8.1%,
control, 73.9 7.4%; cathepsin H, PKD, 69.9 7.1%, control,
71.5 8.6%; N = 4) and thus allowed semiquantitative evaluation
of specific protein bands.
As can be seen in Figure 1, antiserum to cathepsin B recognized
two protein bands of Mr 31 and 29 kDa, respectively, while
cathepsin H gave a single band of Mr 28 kDa in proximal tubules
both from PKD and control rats. These Mr values are consistent
with those reported in the literature [39—41]. Densitometric
evaluation showed that tubular cathepsin B and H proteins from
PKD rats were 2.4 0.7-fold and 1.9 0.6-fold (N = 4,P < 0.05)
lower as compared to control animals. To demonstrate cathepsin
L protein in isolated tubules, a polyclonal antiserum to human
cathepsin L was used both in ELISA technique and Western blot
analysis. However, there was no cross-reactivity with rat cathepsin
L and therefore, we could not obtain data on cathepsin L protein.
Tubular mRNA expression of cathepsins B, H and L
Northern blot analyses of cathepsin B, H and L were performed
in proximal tubules from PKD and control rats (Fig. 2). Densito-
metric evaluation of of signals for cathepsins B, H and L mRNAs
(each mRNA was probed 3 times) revealed no difference between
proximal tubules from PKD and those from control animals.
Marker enzymes for subcellular comparments of proximal tubules
To examine whether proximal PKD tubules displayed more
wide spread disturbancies of other enzyme systems (as oppossed
to a more specific alteration in lysosomal cathepsins) other
kDa PKD Control
Cathepsin B
PKD Control
Cathepsin H
Fig. 1. Western blot analysis of cathepsins B and H in proximal tubules
isolated from PKD and control rats. Polyclonal antibody to rat cathepsin B
recognized 2 bands of Mr 31 and 29 kDa, while polyclonal antibody to
human cathepsin H recognized a single band of Mr 28 kDa. Enzyme
proteins, measured by densitometry was for cathepsin B 2.4 0.7-fold and
for cathepsin H 1.9 0.6-fold lower (N = 4; P < 0.05) in tubular
preparations of PKD animals.
lysosomal enzymes (/3-NAG and acid phosphatase) and enzymes
from other subcellular compartments, such as mitochondria (cy-
tochrome c oxidase), endoplasmatic reticulum (glucose-6-phos-
phatase) and cytosol (lactate dehydrogenase) were determined.
There was 1.7-fold reduction in p-NAG activity in proximal PKD
tubules, while acid phosphatase activity was unchanged. In terms
of cytochrome c oxidase, glucose-6-phosphatase and lactate dehy-
drogenase there was no difference between tubules from PKD and
control animals (Table 3).
Cathepsin activities in isolated glomeruli and liver samples
To examine whether alterations of cathepsin activities occur
only in proximal tubules in PKD animals and are specific for those
cells involved in cystogenesis or can be observed in other parts of
the kidney or other tissues as well, activities of these enzymes were
measured in isolated glomeruli and liver samples. Both glomeruli
and liver are not affected in the male, heterozygous Han:SPRD
rat.
The amount of isolated glomeruli obtained from one kidney
was comparable in both groups (PKD 24,183 1,863 vs. controls
25,014 1,524 glomeruli/kidney; N = 9). Liver weights in both
groups were similar (PKD 11.6 1.1vs. controls 12.0 1.2 g;N =
9). There were no differences in the activities of cathepsins B, H
and L neither in glomeruli nor in liver samples obtained from
PKD or control animals (Table 4).
Cathepsin B, H and L in cyst fluid from homozygous PKD rats
Cyst fluid from homozygous PKD rats displayed considerable
activities of cathepsin B (31.6 6.1 mU/ml), cathepsin H (173.2
16.1 mU/mI), as well as cathepsin L (12.9 2.4 mU/ml).
Western blotting using polyclonal antibodies to cathepsins B and
H recognized two protein bands of Mr 31 and 29 kDA in case of
cathepsin B and a single 28 kDa band for cathepsin H (Fig. 3).
Urinary excretion of cathepsins in PKD and control rats
As can be seen in Table 5, urinary excretion of cathepsins B, H
and L activities in PKD rats was 72%, 92% and 79% higher
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PKD Control
Cathepsin B
GAPDH
Cathepsin H
GAPDH
Fig. 2. Northern blot analysis (N 3) of tubular cathepsin B, H and L
mRNAs of PKD and control rats. As measured by densitometry, the levels
of mRNA coding for cathepsin B were identical in PKD and healthy
controls. Expression of GAPDH mRNA in the same membrane is shown
on the bottom panel. The 18S and 28S ribosomal RNA transcripts
detected by ethidium bromide staining are shown on the middle panel to
indicate equality of loading and integrety of RNA.
compared to healthy control animals. Based on our observation
that creatinine clearances were identical in PKD and control rats
(Table 1), enzyme activities were given as activity excreted over 24
hr (mU/24 hr).
Western blot analysis of cathepsin B and H in urine samples of
PKD animals demonstrated the presence of cathepsin B as two
protein bands of 31 and 29 kDa and a single cathepsin H band of
28 kDa. By contrast, cathcpsins B and H were hardly detectable by
Western blotting in the urine of healthy control animals (Fig. 4).
Cystatins in proximal tubules from heterozygous PKD and healthy
control rats
Since alterations of cathepsin activities might be due to changes
in the expression of their specific inhibitors, cystatin A and C were
analyzed in proximal tubules in terms of enzyme protein and
mRNA levels. Western blotting for cystatin C following semipu-
rification of equal amounts of protein from proximal tubular
homogenates revealed a band of 20 kDa (Fig. 5) in accordance
with what has been described previously in homogenates of the
whole rat kidney [421. Densitometric evaluation of this protein
Table 3. Activities of marker enzymes for subcellular compartments of
proximal tubules from heterozygous PKD and control rats
PKD Controls
U/tubular preparation
Lysosomes
13-NAG
Acid phosphatase
Mitochondria
Cytochrome c oxidase
Endoplasmatic reticulum
Glucose-6-phosphatase
Cytosol
Lactate dehydrogenase
2.73 0.35a
8.79 0.71
23.4 5.4
36.2 6.4
42.2 7.3
4.53 0.50
8.98 0.95
21.6 5.0
39.4 5.8
43.0 6.5
Data are given as means SEM from 9 animals in each group. Tubular
preparation represents proximal tubules from one kidney.
"P < 0.05 for PKD vs. healthy offspring (2-months-old)
band (N = 3) did not show any difference in cystatin C protein
content in proximal tubules from PKD and control rats.
In accordance with enzyme protein levels, mRNAs for cystatin
C in both PKD and control tubules, analysed by Northern blotting
(Fig. 6) and subsequent densitometry (N = 3), were comparable.
Cystatin A was not detectable in proximal tubules from PKD and
control animals neither as enzyme protein nor in terms of mRNA.
Discussion
Our findings provide evidence for a reduction of the cysteine
proteinases cathepsin B, H and L both in terms of activity and
enzyme protein in proximal tubules isolated from PKD rats, while
mRNA expression for these enzymes was unchanged. Cystatin C,
a major inhibitor of lysosomal cysteine proteinases, apparently did
not contribute to the reduced cathepsin activities, since its protein
levels and expression of mRNA were not altered.
This decrement in proteinase activity appears to be specific for
proximal tubules, since renal glomeruli and liver slices displayed
no such alterations. Moreover, these disturbances were limited to
lysosomal hydrolases, because marker enzymes for other intracel-
lular compartments (cytosol, mitochondria and endoplasmatic
reticulum) were unchanged in proximal tubules from PKD ani-
mals. Finally, the alterations in lysosomal enzymes affected only
cathepsins B, H and L as well as p-NAG, while lysosomal acid
phosphatase was unchanged in PKD rats. Luminal secretion of
tubular cathepsins appeared to be enhanced, as cathepsins could
be demonstrated in cyst fluid and the urinary excretion of these
enzymes was found to be increased.
In general, there are only a few preliminary reports which
address the potential involvement of lysosomal proteinases in the
evolution of PKD [20, 21]. Using kidney homogenates from
ADPKD patients, Wilson and Hartz [20] found a deficit in
lysosomal proteinases measured against azocasein as a substrate.
They were able to confirm this finding when they determined
cathepsin B, H and L activities by using specific substrates in
cultured human cyst epithelia.
These authors [20, 21] hypothetized that the decrement in
lysosomal enzyme activity might be due to a central error in
protein targeting in cyst epithelia. This would fit quite well to our
findings in kidney tubules from the heterozygous Han:SPRD rat,
which suggested enhanced secretion of cathepsins into the lumen
1.4kb
1.8kb
GAPDH
Cathepsin L
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Table 4. Cathepsin activities in isolated glomeruli and liver samples
from heterozygous PKD and control rats
Cathepsin B Cathepsin H Cathepsin L
Glomeruli mU/HJ glomeruli
PKD 39.4 3.2 22.6 1.6 24.0 2.0
Controls 42.3 4.2 21.6 1.9 25.1 3.0
Liver mU/mg protein
PKD 385 29 180 19 542 61
Controls 363 31 163 20 569 59
Cathepsin B Cathepsin H
Fig. 3. Western blot analysis (N = 4) of cyst fluid from homozygous PKD
rats. Polyclonal antibody to rat cathepsin B recognized 2 bands of Mr 31
and 29 kDa, while polyclonal antibody to human cathepsin H bound to a
single band of Mr 28 kDa.
Table 5. Urinary excretion of cathepsin activities in heterozygous PKD
and control rats
Cathepsin B Cathepsin H Cathepsin L
mU/24 hr
PKD 115.9 6.8a 110.2 9.Oa 153.6 13.1
Controls 67.3 7.1 57.4 5.2 85.8 9.4
in terms of activity and enzyme protein, while the respective
mRNA levels remained unchanged. Alterations in the polarized
transport of specific proteins have indeed been shown to occur in
PKD epithelia. Thus, the Na/K-ATPase which normally is inserted
into the basolateral membrane has been found to be mislocated to
apical plasma membranes [43].
Besides enhanced secretion of lysosomal cysteine proteinases,
reduced cathepsin activities might also have been due to an
increase in the specific intracellular inhibitors. In general, cysteine
proteinases are controlled by a class of inhibitors referred to as
cystatins [44]. Cystatin C is expressed in many human tissues
including the kidney and can be found in the circulation [45],
while cystatin A is selectively expressed in epithelial cells and
polymorphonuclear leukocytes [46]. In the present experiment, we
studied mRNA and protein levels of cystatins A and C in isolated
proximal tubules from PKD rats. In terms of cystatin C, both
mRNA and protein levels were not altered in kidney tubules from
PKD animals. Cystatin A, on the other hand, could not be
Cathepsin B Cathepsin H
Fig. 4. Western blot analysis (N = 4) of urinary cathepsins B and H from
PKD and control rats. Cathepsin B (bands of 31 and 29 kDa) and H (28
kDa band) proteins in urine from PKD rats can be clearly recognized. In
the urine from healthy controls cathepsins B and H were almost not
detectable.
Cystatin C
Fig. 5. Western blot analysis (N = 3) of cystatin C in proximal tubules
isolated from PKD and control rats. Polyclonal antibody to human cystatin
C recognized a single band of 20 kDa. Densitometric evaluation indicated
that there was no difference between PKD and control animals.
demonstrated neither by Northern nor by Western blotting in
tubules from normal or PKD animals. Taken together, these
results suggest that intracellular cysteine proteinase inhibitors
appear unlikely to have contributed to the reduction in cathepsin
activities in PKD tubules.
Interestingly, not all lysosomal enzyme activities were found to
be reduced in PKD tubules, since the activity of lysosomal acid
phosphatase was normal. This may point to a possible mechanism
by which these disturbances in lysosomal enzymes are brought
about. Acid hydrolases are synthetized in the endoplasmatic
reticulum and then transported to the Golgi apparatus, where
their oligosaccharide side chains are modified to contain man-
nose-6-phosphate. In the trans-Golgi network hydrolases then
bind to the mannose-6-phosphate receptor and are transferred to
endosomes. Here the hydrolases dissociate from the receptor and
subsequently reach the lysosome. Lack or alteration of the
mannose-6-phosphate receptor results in extracellular secretion
of newly synthetized hydrolases [46]. Among these hydrolases,
acid phosphatase resembles lysosomal membrane proteins which
are, in contrast to soluble proteins of the lysosomal matrix
(cathepsins B, H and L and /3-NAG), routed from the Golgi
complex to lysosomes independently of the mannose-6-phosphate
receptor [47, 48].
Together with ultrastructural findings by Carone, Bacallao and
Kanwar [49] that the Golgi complex is altered in tubular epithe-
hum from polycystic kidneys, the above-mentioned considerations
kDa PKD Control PKD Control
Data are given as means SEM from 9 animals in each group.
kDa
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29 —
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20 —
Data are given as means SEM from 9 animals in each group.
a P < 0.05 for PKD vs. healthy offspring (2-months-old)
S
28 —
Cit
1.4kb
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Fig. 6. Northernblot analysis (N = 3) of tubular cystatin C mRNA of PKD
and control rats. The levels of mRNA for cystatin C, measured by
densitometry, did not differ between both groups. The middle panel shows
ethidium bromide staining of 18S and 28S ribosomal RNA transcripts.
Expression of GAPDH mRNA in the same membrane is shown on the
bottom panel.
and our findings that there are differences in the handling of
lysosomal acid hydrolases in PKD tubules suggest that trans-Golgi
network signal mechanisms may be defective in tubular PKD
epithelium leading to enhanced secretion of lysosomal hydrolases
instead of storage within lysosomes.
Finally, the question remains whether a reduction in the
activities of cathepsins does infact translate into alterations of
extracellular matrix turnover in the kidney in PKD. While there is
no direct evidence presently available, several observations sug-
gest a close relationship. Abnormal matrix turnover occurs early
during the course of human ADPKD [2, 3] as well as in the
Han:SPRD rat model [24] and cathepsins B and L have been
shown to degrade collagen IV, laminin and fibronectin in vitro not
only at acid but also at neutral pH [50]. Therefore, decreased
levels of cathepsins could lead to accumulation of matrix compo-
nents.
In addition, in our experiment alterations of cathepsins were
limited to proximal tubules. Glomeruli and liver tissue of the PKD
animals displayed normal cathepsin activities. As cyst formation in
the male Han:SPRD rat predominantly occurs in proximal tubules
[24], while glomeruli [51] and liver are unaffected [52], it is
conceivable that the reduction in tubular cathepsins may play a
role in cyst formation in PKD.
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